These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 25851448)
1. Antiphospholipid syndrome: an update. Merashli M; Noureldine MH; Uthman I; Khamashta M Eur J Clin Invest; 2015 Jun; 45(6):653-62. PubMed ID: 25851448 [TBL] [Abstract][Full Text] [Related]
2. The antiphospholipid syndrome: still an enigma. Chaturvedi S; McCrae KR Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701 [TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and management of antiphospholipid syndrome. Arachchillage DRJ; Laffan M Br J Haematol; 2017 Jul; 178(2):181-195. PubMed ID: 28339096 [TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future. Mehdi AA; Uthman I; Khamashta M Eur J Clin Invest; 2010 May; 40(5):451-64. PubMed ID: 20345380 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of the antiphospholipid syndrome. Chaturvedi S; McCrae KR Blood Rev; 2017 Nov; 31(6):406-417. PubMed ID: 28784423 [TBL] [Abstract][Full Text] [Related]
7. Thrombotic risk assessment in APS: the Global APS Score (GAPSS). Sciascia S; Bertolaccini ML Lupus; 2014 Oct; 23(12):1286-7. PubMed ID: 25228728 [TBL] [Abstract][Full Text] [Related]
8. Current status and future prospects for the treatment of antiphospholipid syndrome. Al Marzooqi A; Leone A; Al Saleh J; Khamashta M Expert Rev Clin Immunol; 2016 Sep; 12(9):927-35. PubMed ID: 27117597 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: analysis of 24 cases from the bibliography review]. Pons I; Espinosa G; Cervera R Med Clin (Barc); 2015 Feb; 144(3):97-104. PubMed ID: 24698717 [TBL] [Abstract][Full Text] [Related]
10. Recognition and management of antiphospholipid syndrome. Gerosa M; Meroni PL; Erkan D Curr Opin Rheumatol; 2016 Jan; 28(1):51-9. PubMed ID: 26599382 [TBL] [Abstract][Full Text] [Related]
11. Novel insights into pathogenesis, diagnosis and treatment of antiphospholipid syndrome. Wijetilleka S; Scoble T; Khamashta M Curr Opin Rheumatol; 2012 Sep; 24(5):473-81. PubMed ID: 22585233 [TBL] [Abstract][Full Text] [Related]
15. Thrombotic Management of Antiphospholipid Syndrome: Towards Novel Targeted Therapies. Islam MA; Alam F; Wong KK; Kamal MA; Gan SH Curr Vasc Pharmacol; 2017; 15(4):313-326. PubMed ID: 28056758 [TBL] [Abstract][Full Text] [Related]
16. Current management of antiphospholipid syndrome-related thrombosis. Puente D; Pombo G; Forastiero R Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317 [TBL] [Abstract][Full Text] [Related]
17. Management of antiphospholipid syndrome. Rahman A Clin Rheumatol; 2020 Jul; 39(7):2111-2114. PubMed ID: 32458245 [TBL] [Abstract][Full Text] [Related]
19. The relation between antiphospholipid syndrome-related pregnancy morbidity and non-gravid vascular thrombosis: a review of the literature and management strategies. Erkan D Curr Rheumatol Rep; 2002 Oct; 4(5):379-86. PubMed ID: 12217241 [TBL] [Abstract][Full Text] [Related]
20. Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome. Arachchillage DJ; Laffan M; Pericleous C Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]